Palazestrant
CAS: 2092925-89-6
Ref. TM-T72945
| 1mg | 275.00 € | ||
| 5mg | 676.00 € | ||
| 10mg | 924.00 € | ||
| 25mg | 1,422.00 € | ||
| 50mg | 1,852.00 € |
Estimated delivery in United States, on Tuesday 21 Jan 2025
Product Information
Name:
Palazestrant
Synonyms:
- OP-1250
- OP1250
- OP 1250
Description:
Palazestrant, an antiestrogen and antineoplastic agent, effectively targets ER+/HER2+ cancer when used in conjunction with a HER2 inhibitor.
Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Targetmol
Long term storage:
Notes:
Chemical properties
Molecular weight:
449.6
Formula:
C28H36FN3O
Purity:
97.55%
Color/Form:
Liquid
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:
Technical inquiry about: TM-T72945 Palazestrant
Please use instead the cart to request a quotation or an order
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
